FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lutz Heinemann

Research Profile

Chemicals & Drugs

Devices

Glucose Clamp Technique

Disorders

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Leszek Nosek; K Roggen; M Kaiser; S Arnolds; C Gottschalk; Lutz Heinemann; Tim Heise
Insulin aspart has a shorter duration of action than human insulin over a wide dose-range.
Lutz Heinemann; Tim Heise; A Krasner; Leszek Nosek; P Pichotta; K Albus; F Flacke; S Steiner
U-100, pH-Neutral formulation of VIAject(®) : faster onset of action than insulin lispro in patients with type 1 diabetes.
Alexander Strom; Lutz Heinemann; Tim Heise; Christian Herder; Wolfgang Koenig; Hubert Kolb; Stephan Martin; Michael Roden; Nanette C Schloot; Marie-Christine Simon
Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lutz Heinemann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Leszek Nosek; K Roggen; M Kaiser; S Arnolds; C Gottschalk; Lutz Heinemann; Tim Heise
Insulin aspart has a shorter duration of action than human insulin over a wide dose-range.
Diabetes, obesity & metabolism 2013;15(1):77-83.
2012: Lutz Heinemann; Tim Heise; A Krasner; Leszek Nosek; P Pichotta; K Albus; F Flacke; S Steiner
U-100, pH-Neutral formulation of VIAject(®) : faster onset of action than insulin lispro in patients with type 1 diabetes.
Diabetes, obesity & metabolism 2012;14(3):222-7.
2012: Alexander Strom; Lutz Heinemann; Tim Heise; Christian Herder; Wolfgang Koenig; Hubert Kolb; Stephan Martin; Michael Roden; Nanette C Schloot; Marie-Christine Simon
Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial).
PloS one 2012;7(3):e33108.
2011: Lutz Heinemann; Dirk Boecker
Lancing: quo vadis?
Journal of diabetes science and technology 2011;5(4):966-81.
2011: Lutz Heinemann; Marcus Hompesch
Biosimilar insulins: how similar is similar?
Journal of diabetes science and technology 2011;5(3):741-54.
2011: Lutz Heinemann; Marcus Hompesch; Andreas Pfützner; Rody Pohl; Patrick Simms; Kerstin Albus; Frank Flacke; Solomon Steiner
Reduction of postprandial glycemic excursions in patients with type 1 diabetes: a novel human insulin formulation versus a rapid-acting insulin analog and regular human insulin.
Journal of diabetes science and technology 2011;5(3):681-6.
2011: Ronald J Pettis; Barry Ginsberg; Laurence Hirsch; Diane Sutter; Steven Keith; Elaine McVey; Noel G Harvey; Marcus Hompesch; Leszek Nosek; Christoph Kapitza; Lutz Heinemann
Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection.
Diabetes technology & therapeutics 2011;13(4):435-42.
2011: Ronald J Pettis; Laurence Hirsch; Christoph Kapitza; Leszek Nosek; Ulrike Hövelmann; Heinz-Joerg Kurth; Diane E Sutter; Noel G Harvey; Lutz Heinemann
Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes.
Diabetes technology & therapeutics 2011;13(4):443-50.
2010: Lutz Heinemann
Analysis of the Nova Stat Strip® glucose meter for real-time blood glucose determinations during glucose clamp studies: "don't swap horses in midstream".
Journal of diabetes science and technology 2010;4(5):1202-4.
2010: Lutz Heinemann
Insulin absorption from lipodystrophic areas: a (neglected) source of trouble for insulin therapy?
Journal of diabetes science and technology 2010;4(3):750-3.
2010: Lutz Heinemann
New ways of insulin delivery.
International journal of clinical practice. Supplement 2010;(166):29-40.
2010: Klaus Rave; Patricia N Sidharta; Jasper Dingemanse; Lutz Heinemann; Kerstin Roggen
First-phase insulin secretion has limited impact on postprandial glycemia in subjects with type 2 diabetes: correlations between hyperglycemic glucose clamp and meal test.
Diabetes technology & therapeutics 2010;12(2):117-23.
2010: Christoph Kapitza; Ulrike Hövelmann; Leszek Nosek; Heinz-Joerg Kurth; Matthias Essenpreis; Lutz Heinemann
Continuous glucose monitoring during exercise in patients with type 1 diabetes on continuous subcutaneous insulin infusion.
Journal of diabetes science and technology 2010;4(1):123-31.
2009: Amparo de la Peña; Mary Seger; Klaus Rave; Lutz Heinemann; Bernard Silverman; Douglas B Muchmore
AIR insulin capsules of different dose strengths may be combined to yield equivalent pharmacokinetics and glucodynamics.
Diabetes technology & therapeutics 2009;11 Suppl 2():S75-80.
2009: Tim Heise; Lutz Heinemann; Ulrike Hövelmann; Bianca Brauns; Leszek Nosek; Hanne L Haahr; Klaus J Olsen
Biphasic insulin aspart 30/70: pharmacokinetics and pharmacodynamics compared with once-daily biphasic human insulin and Basal-bolus therapy.
Diabetes care 2009;32(8):1431-3.
2009: Lutz Heinemann; Leszek Nosek; Christoph Kapitza; Matthias Axel Schweitzer; Lars Krinelke
Changes in basal insulin infusion rates with subcutaneous insulin infusion: time until a change in metabolic effect is induced in patients with type 1 diabetes.
Diabetes care 2009;32(8):1437-9.
2009: S Wolf; Klaus Rave; Lutz Heinemann; K Roggen
Renal glucose excretion and tubular reabsorption rate related to blood glucose in subjects with type 2 diabetes with a critical reappraisal of the "renal glucose threshold" model.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2009;41(8):600-4.
2009: Lutz Heinemann
Continuous glucose monitoring and clinical trials.
Journal of diabetes science and technology 2009;3(4):981-5.
2009: Lutz Heinemann; Yves Jacques
Oral insulin and buccal insulin: a critical reappraisal.
Journal of diabetes science and technology 2009;3(3):568-84.
2009: T Heise; A Brugger; C Cook; U Eckers; A Hutchcraft; Leszek Nosek; Klaus Rave; J Troeger; P Valaitis; S White; Lutz Heinemann
PROMAXX inhaled insulin: safe and efficacious administration with a commercially available dry powder inhaler.
Diabetes, obesity & metabolism 2009;11(5):455-9.
2009: Stephan Martin; Hubert Kolb; Berthold Schneider; Lutz Heinemann; Christian Weber; Serge Kocher; Jacques K T Tshiananga; Werner A Scherbaum; Volker Lodwig
Myocardial infarction and stroke in early years after diagnosis of type 2 diabetes: risk factors and relation to self-monitoring of blood glucose.
Diabetes technology & therapeutics 2009;11(4):234-41.
2008: B Rose; M Lankisch; Christian Herder; Karin Röhrig; Kerstin Kempf; S Labrenz; J Hänsler; Wolfgang Koenig; Lutz Heinemann; Stephan Martin
Beneficial effects of external muscle stimulation on glycaemic control in patients with type 2 diabetes.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2008;116(10):577-81.
2008: Theodor Koschinsky; Sascha Heckermann; Lutz Heinemann
Parameters affecting postprandial blood glucose: effects of blood glucose measurement errors.
Journal of diabetes science and technology 2008;2(1):58-66.
2007: Lutz Heinemann
Future directions for insulin therapy and diabetes treatment.
Endocrinology and metabolism clinics of North America 2007;36 Suppl 2():69-79.
2007: Reinhard H A Becker; Annke D Frick; Leszek Nosek; Lutz Heinemann; Klaus Rave
Dose-response relationship of insulin glulisine in subjects with type 1 diabetes.
Diabetes care 2007;30(10):2506-7.
2007: Stephan Martin; W Schramm; Berthold Schneider; Kurt Neeser; C Weber; Volker Lodwig; Lutz Heinemann; Werner A Scherbaum; Hubert Kolb
Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4).
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2007;115(8):495-501.
2007: Tim Heise; Leszek Nosek; H Spitzer; Lutz Heinemann; E Niemöller; Annke D Frick; Reinhard H A Becker
Insulin glulisine: a faster onset of action compared with insulin lispro.
Diabetes, obesity & metabolism 2007;9(5):746-53.
2007: Klaus Rave; Amparo de la Peña; Fabián S Tibaldi; Liping Zhang; Bernard Silverman; Michaela Hausmann; Lutz Heinemann; Douglas B Muchmore
AIR inhaled insulin in subjects with chronic obstructive pulmonary disease: pharmacokinetics, glucodynamics, safety, and tolerability.
Diabetes care 2007;30(7):1777-82.
2007: Lutz Heinemann
Future directions in insulin therapy and treatment of diabetes mellitus: a critical comment.
Clinical cornerstone 2007;8(2):66-74.
2007: Hubert Kolb; Berthold Schneider; Lutz Heinemann; Volker Lodwig; Stephan Martin
Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study.
Diabetes care 2007;30(1):183-4; author reply 184-5.
2006: M Hausmann; S Dellweg; C Osborn; Lutz Heinemann; A Buchwald; R Rosskamp; P Genova; Tim Heise
Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof-of-concept study.
Diabetes, obesity & metabolism 2006;8(5):574-80.
2006: Marcus Hompesch; B Troupin; Tim Heise; B Elbroend; Lars A Endahl; H Haahr; Lutz Heinemann
Time-action profile of insulin detemir and NPH insulin in patients with type 2 diabetes from different ethnic groups.
Diabetes, obesity & metabolism 2006;8(5):568-73.
2006: Hans-Jörg Wittsack; Christoph Kapitza; Mathias Cohnen; G Jung; Lutz Heinemann; Ulrich Mödder; Ludger W Poll
[Interactive thresholded volumetry of abdominal fat using breath-hold t1-weighted magnetic resonance imaging].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2006;178(8):810-5.
2006: Stephan Martin; Berthold Schneider; Lutz Heinemann; Volker Lodwig; H-J Kurth; Hubert Kolb; Werner A Scherbaum
Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study.
Diabetologia 2006;49(2):271-8.
2005: Susanne Bott; Corinna Tusek; Lutz Heinemann; H H Friberg; Tim Heise
The pharmacokinetic and pharmacodynamic properties of biphasic insulin Aspart 70 (BIAsp 70) are significantly different from those of biphasic insulin Aspart 30 (BIAsp 30).
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2005;113(9):545-50.
2005: Klaus Rave; Leszek Nosek; Amparo de la Peña; Mary Seger; Charles S Ernest; Lutz Heinemann; Richard P Batycky; Douglas B Muchmore
Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro.
Diabetes care 2005;28(10):2400-5.
2005: Klaus Rave; Sabine Flesch; W Nikolaus Kühn-Velten; Beate C Hompesch; Lutz Heinemann; Tim Heise
Enhancement of blood glucose lowering effect of a sulfonylurea when coadministered with an ACE inhibitor: results of a glucose-clamp study.
Diabetes/metabolism research and reviews 2005;21(5):459-64.
2005: Klaus Rave; Susanne Bott; Lutz Heinemann; Sue Sha; Reinhard H A Becker; Susan A Willavize; Tim Heise
Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin.
Diabetes care 2005;28(5):1077-82.
2004: Ludger W Poll; Hans-Jörg Wittsack; Reinhart Willers; Ulrich Mödder; Lutz Heinemann; Christoph Kapitza; Klaus Rave
Correlation between anthropometric parameters and abdominal fat volumes assessed by a magnetic resonance imaging method in patients with diabetes.
Diabetes technology & therapeutics 2004;6(6):844-9.
2004: Lutz Heinemann; James H Anderson
Measurement of insulin absorption and insulin action.
Diabetes technology & therapeutics 2004;6(5):698-718.
2004: Lutz Heinemann
Overcoming obstacles: new management options.
European journal of endocrinology / European Federation of Endocrine Societies 2004;151 Suppl 2():T23-7; discussion T29-30.
2004: Tim Heise; Lutz Heinemann; Simon Heller; Christian Weyer; Yan Wang; Susan Strobel; Orville G Kolterman; David G Maggs
Effect of pramlintide on symptom, catecholamine, and glucagon responses to hypoglycemia in healthy subjects.
Metabolism: clinical and experimental 2004;53(9):1227-32.
2004: Klaus Rave; Leszek Nosek; Lutz Heinemann; C Gonzales; Charles S Ernest; J Chien; Douglas B Muchmore
Inhaled micronized crystalline human insulin using a dry powder inhaler: dose-response and time-action profiles.
Diabetic medicine : a journal of the British Diabetic Association 2004;21(7):763-8.
2004: Tim Heise; Leszek Nosek; Birgitte Biilmann Rønn; Lars A Endahl; Lutz Heinemann; Christoph Kapitza; Eberhard Draeger
Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.
Diabetes 2004;53(6):1614-20.
2004: Klaus Rave; Leszek Nosek; Lutz Heinemann; Annke D Frick; R Becker; Christoph Kapitza
Dependency of the metabolic effect of sc-injected human regular insulin on intra-abdominal fat in patients with type 2 diabetes.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2004;36(5):307-11.
2004: Christoph Kapitza; Klaus Rave; K Ostrowski; Tim Heise; Lutz Heinemann
Reduced postprandial glycaemic excursion with biphasic insulin Aspart 30 injected immediately before a meal.
Diabetic medicine : a journal of the British Diabetic Association 2004;21(5):500-1.
2004: Christoph Kapitza; Tim Heise; Robert S Fishman; David A Shapiro; Vidhya Gopalakrishnan; Klaus Rave; Susanne Bott; Ayesh D Perera; Lutz Heinemann
Impact of particle size and aerosolization time on the metabolic effect of an inhaled insulin aerosol.
Diabetes technology & therapeutics 2004;6(2):119-27.
2003: Klaus Rave; Leszek Nosek; Lutz Heinemann; Annke D Frick; R Becker
Time-action profile of the long-acting insulin analogue insulin glargine in comparison to NPH insulin in Japanese volunteers.
Diabetes & metabolism 2003;29(4 Pt 1):430-1.
2003: Ludger Wilhelm Poll; Hans-Jörg Wittsack; Jens-Albrecht Koch; Reinhart Willers; Mathias Cohnen; Christoph Kapitza; Lutz Heinemann; Ulrich Mödder
A rapid and reliable semiautomated method for measurement of total abdominal fat volumes using magnetic resonance imaging.
Magnetic resonance imaging 2003;21(6):631-6.
2003: Theodor Koschinsky; Karsten Jungheim; Lutz Heinemann
Glucose sensors and the alternate site testing-like phenomenon: relationship between rapid blood glucose changes and glucose sensor signals.
Diabetes technology & therapeutics 2003;5(5):829-42.
2003: Christoph Kapitza; Volker Lodwig; Karin Obermaier; Klaas Jan C Wientjes; Klaas Hoogenberg; Karsten Jungheim; Lutz Heinemann
Continuous glucose monitoring: reliable measurements for up to 4 days with the SCGM1 system.
Diabetes technology & therapeutics 2003;5(4):609-14.
2003: Volker Lodwig; Lutz Heinemann
Continuous glucose monitoring with glucose sensors: calibration and assessment criteria.
Diabetes technology & therapeutics 2003;5(4):572-86.
2003: Tim Heise; Theodor Koschinsky; Lutz Heinemann; Volker Lodwig
Hypoglycemia warning signal and glucose sensors: requirements and concepts.
Diabetes technology & therapeutics 2003;5(4):563-71.
2003: Lutz Heinemann
Continuous glucose monitoring by means of the microdialysis technique: underlying fundamental aspects.
Diabetes technology & therapeutics 2003;5(4):545-61.
2002: Ayesh D Perera; Christoph Kapitza; Leszek Nosek; Robert S Fishman; David A Shapiro; Tim Heise; Lutz Heinemann
Absorption and metabolic effect of inhaled insulin: intrapatient variability after inhalation via the Aerodose insulin inhaler in patients with type 2 diabetes.
Diabetes care 2002;25(12):2276-81.
2002: Ludger W Poll; Hans-Jörg Wittsack; Jens-Albrecht Koch; Reinhart Willers; A Scherer; Christoph Kapitza; Lutz Heinemann; Ulrich Mödder
Quantification of total abdominal fat volumes using magnetic resonance imaging.
European journal of medical research 2002;7(8):347-52.
2002: Lutz Heinemann; Theodor Koschinsky
Continuous glucose monitoring: an overview of today's technologies and their clinical applications.
International journal of clinical practice. Supplement 2002;(129):75-9.
2002: Tim Heise; Susanne Bott; Klaus Rave; A Dressler; R Rosskamp; Lutz Heinemann
No evidence for accumulation of insulin glargine (LANTUS): a multiple injection study in patients with Type 1 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 2002;19(6):490-5.
2002: Thomas Forst; Klaus Rave; Andreas Pfuetzner; Ronald Buchholz; Thomas Pohlmann; Mirjam Löbig; Lutz Heinemann
Effect of C-peptide on glucose metabolism in patients with type 1 diabetes.
Diabetes care 2002;25(6):1096-7.
2002: Lutz Heinemann
Variability of insulin absorption and insulin action.
Diabetes technology & therapeutics 2002;4(5):673-82.
2002: S Steiner; Andreas Pfützner; B R Wilson; O Harzer; Lutz Heinemann; Klaus Rave
Technosphere/Insulin--proof of concept study with a new insulin formulation for pulmonary delivery.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2002;110(1):17-21.
2001: Karsten Jungheim; Klaas Jan C Wientjes; Lutz Heinemann; Volker Lodwig; Theodor Koschinsky; Adelbert J M Schoonen
Subcutaneous continuous glucose monitoring: feasibility of a new microdialysis-based glucose sensor system.
Diabetes care 2001;24(9):1696-7.
2001: Klaus Rave; Tim Heise; Andreas Pfützner; Lutz Heinemann; Peter T Sawicki
Impact of diabetic nephropathy on pharmacodynamic and Pharmacokinetic properties of insulin in type 1 diabetic patients.
Diabetes care 2001;24(5):886-90.
2001: Theodor Koschinsky; Lutz Heinemann
Sensors for glucose monitoring: technical and clinical aspects.
Diabetes/metabolism research and reviews 2001;17(2):113-23.
2001: Lutz Heinemann
Chronic intermittent intravenous insulin therapy: really a new therapeutic option?
Diabetes technology & therapeutics 2001;3(1):125-7.
2000: Lutz Heinemann; W Klappoth; Klaus Rave; Beate C Hompesch; R Linkeschowa; Tim Heise
Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer.
Diabetes care 2000;23(9):1343-7.
2000: Tim Heise; K Magnusson; B Gröbel; Lutz Heinemann; Klaus Rave; R Bender; Peter T Sawicki
A cross-over evaluation of different methods and devices to measure blood pressure in type 1 diabetic patients with nephropathy.
Blood pressure monitoring 2000;5(3):175-80.
2000: Lutz Heinemann; R Linkeschova; Klaus Rave; Beate C Hompesch; M Sedlak; Tim Heise
Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.
Diabetes care 2000;23(5):644-9.
2000: Lutz Heinemann; U Krämer; H M Klötzer; M Hein; D Volz; M Hermann; Tim Heise; Klaus Rave
Noninvasive glucose measurement by monitoring of scattering coefficient during oral glucose tolerance tests. Non-Invasive Task Force.
Diabetes technology & therapeutics 2000;2(2):211-20.
2000: Lutz Heinemann
[Continuous monitoring of blood glucose by non-invasive methods].
Journées annuelles de diabétologie de l'Hôtel-Dieu 2000;():75-86.
1999: Tim Heise; Lutz Heinemann; K Kristahn; M Berger; Peter T Sawicki
Insulin sensitivity in patients with essential hypertension: no influence of the ACE inhibitor enalapril.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1999;31(7):418-23.
1999: Klaus Rave; Lutz Heinemann; L Puhl; U Gudat; James R Woodworth; C Weyer; Tim Heise
Premixed formulations of insulin lispro. Activity profiles in type 1 diabetic patients.
Diabetes care 1999;22(5):865-6.
1999: Lutz Heinemann; K Sinha; C Weyer; M Loftager; S Hirschberger; Tim Heise
Time-action profile of the soluble, fatty acid acylated, long-acting insulin analogue NN304.
Diabetic medicine : a journal of the British Diabetic Association 1999;16(4):332-8.
1999: Klaus Rave; Tim Heise; P Clausson; S Hirschberger; Lutz Heinemann
Lack of effects of the beta3-adrenoreceptor agonist UL-TG 307 on insulin sensitivity and insulin secretion in Type 2 diabetic patients.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1999;107(7):442-6.
1999: Klaus Rave; Tim Heise; C Weyer; Peter T Sawicki; Lutz Heinemann
Measurement of insulin sensitivity: influence of potassium supply during euglycaemic glucose clamps in healthy volunteers.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1999;107(5):313-7.
1999: Renate Kimmerle; Lutz Heinemann; Tim Heise; R Bender; C Weyer; S Hirschberger; M Berger
Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
Menopause (New York, N.Y.) 1999;6(1):36-42.
1998: J Meinhold; Tim Heise; Klaus Rave; Lutz Heinemann
Electrocardiographic changes during insulin-induced hypoglycemia in healthy subjects.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1998;30(11):694-7.
1998: Lutz Heinemann; C Weyer; M Rauhaus; S Heinrichs; Tim Heise
Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart.
Diabetes care 1998;21(11):1910-4.
1998: Tim Heise; Lutz Heinemann; Achim Starke
Simulated postaggression metabolism in healthy subjects: metabolic changes and insulin resistance.
Metabolism: clinical and experimental 1998;47(10):1263-8.
1998: Klaus Rave; Tim Heise; C Weyer; J Herrnberger; R Bender; S Hirschberger; Lutz Heinemann
Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects.
Diabetic medicine : a journal of the British Diabetic Association 1998;15(9):747-51.
1998: Tim Heise; K Magnusson; Lutz Heinemann; Peter T Sawicki
Insulin resistance and the effect of insulin on blood pressure in essential hypertension.
Hypertension 1998;32(2):243-8.
1998: Lutz Heinemann; G Schmelzeisen-Redeker
Non-invasive continuous glucose monitoring in Type I diabetic patients with optical glucose sensors. Non-Invasive Task Force (NITF).
Diabetologia 1998;41(7):848-54.
1998: Tim Heise; C Weyer; A Serwas; S Heinrichs; J Osinga; P Roach; James R Woodworth; U Gudat; Lutz Heinemann
Time-action profiles of novel premixed preparations of insulin lispro and NPL insulin.
Diabetes care 1998;21(5):800-3.
1998: U Gudat; S Bungert; F Kemmer; Lutz Heinemann
The blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 1998;15(3):194-8.
1997: C Weyer; Tim Heise; Lutz Heinemann
Insulin aspart in a 30/70 premixed formulation. Pharmacodynamic properties of a rapid-acting insulin analog in stable mixture.
Diabetes care 1997;20(10):1612-4.
1997: R Windecker; Lutz Heinemann; Peter T Sawicki
Self monitoring of blood glucose in blind diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 1997;14(8):703-6.
1997: Mathias Berger; Lutz Heinemann
Are presently available insulin analogues clinically beneficial?
Diabetologia 1997;40 Suppl 2():S91-6.
1997: U Gudat; G Convent; Lutz Heinemann
Metformin and exercise: no additive effect on blood lactate levels in health volunteers.
Diabetic medicine : a journal of the British Diabetic Association 1997;14(2):138-42.
1997: Lutz Heinemann; C Weyer; Klaus Rave; O Stiefelhagen; M Rauhaus; Tim Heise
Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 Asp.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1997;105(3):140-4.
1997: Lutz Heinemann; T Traut; Tim Heise
Time-action profile of inhaled insulin.
Diabetic medicine : a journal of the British Diabetic Association 1997;14(1):63-72.
1996: Lutz Heinemann; I Janicke; R Bender; M Berger; Peter T Sawicki
Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1996;28(10):549-52.
1996: Lutz Heinemann; C Kapitza; Achim Starke; Tim Heise
Time-action profile of the insulin analogue B28Asp.
Diabetic medicine : a journal of the British Diabetic Association 1996;13(7):683-4.
1996: Lutz Heinemann; Tim Heise; L C Wahl; M E Trautmann; J Ampudia; Achim Starke; Mathias Berger
Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin.
Diabetic medicine : a journal of the British Diabetic Association 1996;13(7):625-9.
1996: U Gudat; Lutz Heinemann
Ø[The effect of physical exercise on glycemia on healthy subjects following administration of glimepiride].
Arzneimittel-Forschung 1996;46(6):606-9.
1996: Peter T Sawicki; Ingrid Mühlhauser; R Bender; W Pethke; Lutz Heinemann; Mathias Berger
Effects of smoking on blood pressure and proteinuria in patients with diabetic nephropathy.
Journal of internal medicine 1996;239(4):345-52.
1995: Lutz Heinemann; Tim Heise; A Klepper; J Ampudia; R Bender; Achim Starke
Time-action profiles of the intermediate-acting insulin analogue des(64,65)-human proinsulin.
Diabète & métabolisme 1995;21(6):415-9.
1995: R Kimmerle; Lutz Heinemann; Mathias Berger
Intrauterine devices are safe and effective contraceptives for type I diabetic women.
Diabetes care 1995;18(11):1506-7.
1995: Lutz Heinemann; Tim Heise; J Ampudia; Peter T Sawicki; G Sindelka; G Brunner; Achim Starke
Four week administration of an ACE inhibitor and a cardioselective beta-blocker in healthy volunteers: no influence on insulin sensitivity.
European journal of clinical investigation 1995;25(8):595-600.
1995: T Baba; Lutz Heinemann; M Berger; Peter T Sawicki
Effect of 4-hour hyperglycaemia and hyperinsulinaemia on plasma atrial natriuretic factor concentrations.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1995;27(2):95-9.
1994: Lutz Heinemann; F J Ampudia-Blasco
Glucose clamps with the Biostator: a critical reappraisal.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1994;26(12):579-83.
1994: F J Ampudia-Blasco; Lutz Heinemann; R Bender; A Schmidt; Tim Heise; Mathias Berger; Achim Starke
Comparative dose-related time-action profiles of glibenclamide and a new non-sulphonylurea drug, AG-EE 623 ZW, during euglycaemic clamp in healthy subjects.
Diabetologia 1994;37(7):703-7.
1994: G Sindelka; Lutz Heinemann; Mathias Berger; W Frenck; Ernst Chantelau
Effect of insulin concentration, subcutaneous fat thickness and skin temperature on subcutaneous insulin absorption in healthy subjects.
Diabetologia 1994;37(4):377-80.
1994: Peter T Sawicki; U Didjurgeit; Ingrid Mühlhauser; R Bender; Lutz Heinemann; Mathias Berger
Smoking is associated with progression of diabetic nephropathy.
Diabetes care 1994;17(2):126-31.
1994: R Kimmerle; T Wimmer; M Markus; Lutz Heinemann; Ernst Günter Vester; Mathias Berger
[Risk factors in hyperlipidemic patients with coronary heart disease one year after PTCA].
Zeitschrift für Kardiologie 1994;83(1):9-15.
1993: Lutz Heinemann; Bernd Richter
Clinical pharmacology of human insulin.
Diabetes care 1993;16 Suppl 3():90-100.
1993: Lutz Heinemann; Tim Heise; L N Jorgensen; Achim Starke
Action profile of the rapid acting insulin analogue: human insulin B28Asp.
Diabetic medicine : a journal of the British Diabetic Association 1993;10(6):535-9.
1993: Lutz Heinemann; Tim Heise; K Kamper
Biotrans: description of a data transfer program for the biostator.
The International journal of artificial organs 1993;16(4):213-7.
1992: R Kimmerle; Lutz Heinemann; A Delecki; Mathias Berger
Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type I diabetic women.
Diabetes care 1992;15(8):1034-7.
1992: Peter T Sawicki; Lutz Heinemann; Achim Starke; Mathias Berger
Hyperinsulinaemia is not linked with blood pressure elevation in patients with insulinoma.
Diabetologia 1992;35(7):649-52.
1992: Lutz Heinemann; Ernst Chantelau; Achim Starke
Pharmacokinetics and pharmacodynamics of subcutaneously administered U40 and U100 formulations of regular human insulin.
Diabète & métabolisme 1992;18(1):21-4.
1992: Lutz Heinemann; Achim Starke; A Hohmann; Mathias Berger
Timing between the subcutaneous administration of insulin and consumption of a carbohydrate rich meal.
Hormone and metabolic research. Supplement series 1992;26():137-9.
1991: Ingrid Mühlhauser; Lutz Heinemann; J Karinganamattom; W Schuwirth; Mathias Berger
Accuracy of blood glucose self monitoring in elderly insulin treated diabetic patients.
Diabète & métabolisme 1991;17(5):476-82.
1991: Ingrid Mühlhauser; Lutz Heinemann; Ellen Fritsche; K von Lennep; Mathias Berger
Hypoglycemic symptoms and frequency of severe hypoglycemia in patients treated with human and animal insulin preparations.
Diabetes care 1991;14(8):745-9.
1991: Peter T Sawicki; S Kaiser; Lutz Heinemann; H Frenzel; Mathias Berger
Prevalence of renal artery stenosis in diabetes mellitus--an autopsy study.
Journal of internal medicine 1991;229(6):489-92.
1990: D Ross; Lutz Heinemann; Ernst Chantelau
Short-term evaluation of an electro-chemical system (ExacTech) for blood glucose monitoring.
Diabetes research and clinical practice 1990;10(3):281-5.
1990: Peter T Sawicki; U Didjurgeit; Ingrid Mühlhauser; Lutz Heinemann; Mathias Berger
Near-normotension and near-normoglycemia in blind type I diabetic patients with overt diabetic nephropathy.
The Journal of diabetic complications 1990;4(4):179-83.
1990: Lutz Heinemann; Achim Starke; L Heding; I Jensen; Mathias Berger
Action profiles of fast onset insulin analogues.
Diabetologia 1990;33(6):384-6.
1989: Lutz Heinemann; G E Sonnenberg; A Hohmann; A Ritzenhoff; Mathias Berger; J Benn; P Sönksen; D Kelley; J Gerich; Thomas Aoki
Pulsatile insulin infusion and glucose-homeostasis in well-controlled type 1 (insulin-dependent) diabetic patients.
Journal of internal medicine 1989;226(5):325-30.
1989: G Mauricio-Leguizamo; Lutz Heinemann; Rüdiger E Scharf; Mathias Berger
Effect of 8 hours of hyperinsulinaemia on haemostatic parameters in healthy man.
Diabetologia 1989;32(8):606-10.
1989: Peter T Sawicki; Lutz Heinemann; Mathias Berger
Comparison of methods for determination of microalbuminuria in diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 1989;6(5):412-5.
1989: Achim Starke; Lutz Heinemann; A Hohmann; Mathias Berger
[Action profile of human ultralente insulin compared with human NPH-insulin].
Deutsche medizinische Wochenschrift (1946) 1989;114(16):618-22.
1989: Achim Starke; Lutz Heinemann; A Hohmann; Mathias Berger
The action profiles of human NPH insulin preparations.
Diabetic medicine : a journal of the British Diabetic Association 1989;6(3):239-44.
1988: Peter T Sawicki; Lutz Heinemann; Klaus Rave; A Hohmann; Mathias Berger
Atrial natriuretic factor in various stages of diabetic nephropathy.
The Journal of diabetic complications 1988;2(4):207-9.
1988: Peter T Sawicki; Lutz Heinemann; Klaus Rave; Mathias Berger
[Atrial natriuretic factor in patients with type 1 diabetes mellitus in various stages of diabetic nephropathy].
Zeitschrift für Kardiologie 1988;77 Suppl 2():111-3.